Year All202620252024202320222021202020192018201720162015201420122011 May 19, 2026 Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 May 7, 2026 Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings Apr 30, 2026 Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update Apr 27, 2026 Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings Apr 23, 2026 Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 Apr 20, 2026 Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer Apr 16, 2026 Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 Apr 1, 2026 Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx Mar 12, 2026 Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award Mar 9, 2026 Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C